mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.039 |
0.5 |
mRNA |
BMS-345541 |
GDSC1000 |
pan-cancer |
AAC |
0.021 |
0.5 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.5 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.5 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
istradefylline |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.5 |
mRNA |
L-685458 |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.5 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.5 |